Trials / Completed
CompletedNCT00231283
NEXUS Study for the Treatment of de Novo Native Coronary Artery Lesions
A Multicenter, Non-Randomized Study of the CYPHER NxT Sirolimus-Eluting Coronary Stent on BX SONIC OVER-THE-WIRE (OTW) Stent Delivery System(SDS)for the Treatment of de Novo Native Coronary Artery Lesions
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Cordis US Corp. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the effectiveness and safety of the CYPHER NxT Sirolimus-eluting Coronary Stent on the BX SONIC Over-the-Wire (OTW) Stent Delivery System (SDS) in patients with de novo native coronary artery lesions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CYPHER NxT SES ON BX SONIC OTW STENT DELIVERY SYSTEM (SDS) | CYPHER NxT Sirolimus-eluting Coronary Stent on the BX SONIC Over-the-wire Stent Delivery System |
Timeline
- Start date
- 2004-04-01
- Completion
- 2005-07-01
- First posted
- 2005-10-04
- Last updated
- 2010-04-20
- Results posted
- 2010-03-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00231283. Inclusion in this directory is not an endorsement.